We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
RANDOX LABORATORIES

Download Mobile App





Oversensitive COVID-19 Tests Detecting Dead Coronavirus Cells, Driving False Positives and Reinfections

By HospiMedica International staff writers
Posted on 07 Sep 2020
Print article
Illustration
Illustration
A study by the Oxford University’s Centre for Evidence-Based Medicine (Oxford, England) suggests that the current COVID-19 diagnostic tests could be too sensitive and may be detecting dead coronavirus cells, leading to overestimated infections.

According to the researchers, the tests used to diagnose COVID-19 are so sensitive that they may be indicating people are infected with SARS-CoV-2 even when they had the virus 70 days ago. Prof Carl Heneghan, director of the Centre for Evidence-Based Medicine, believes that eight days after contracting COVID-19, the chances of an infected person passing on the virus to others become zero if there are no symptoms. However, fragments of the coronavirus can still remain in the body for several weeks afterwards.

Polymerase chain reaction (PCR) tests currently used to detect SARS-CoV-2 have technical limitations as they cannot distinguish whether the virus in the patient is alive or dead. The researchers analyzed 25 studies on PCR tests and found that such tests can suggest people are infected even after their bodies’ immune system has already fought off the coronavirus because these tests only provide a ‘yes’ or ‘no’ as to whether the virus material is in the body. This means such people would test positive even though the coronavirus in their bodies may be harmless and non-infectious.

"After about day eight, you can still find the RNA fragments," Prof Heneghan told BBC Radio 4's Today program. "Some studies have reported up to 70 days that you intermittently shed. You can understand the importance of this, because what you want to do is find those with active infection and not those with the RNA fragments."

“Evidence is mounting that a good proportion of ‘new’ mild cases and people re-testing positive after quarantine or discharge from hospital are not infectious, but are simply clearing harmless virus particles which their immune system has efficiently dealt with,” added Prof Heneghan.

Earlier, a team of South Korean researchers had revealed that reports of recovered coronavirus patients testing positive for SARS-CoV-2 infection a second time round were most likely due to dead-virus fragments. They found that 260 people who had recovered and were declared virus-free tested positive again in South Korea but had little or no contagiousness at all. This meant that they were incapable of transmitting the virus to others, based on virus culture cells that all failed to find live viruses in the recovered patients.

“PCR testing that amplifies genetics of the virus is used in Korea to test COVID-19, and relapse cases are due to technical limits of the PCR testing. The respiratory epithelial cell has a half-life of up to three months, and RNA virus in the cell can be detected with PCR testing one to two months after the elimination of the cell,” said Oh Myoung-don, who spearheads the central clinical committee for emerging disease control in South Korea.

Related Links:
Oxford University’s Centre for Evidence-Based Medicine

Gold Member
Real-Time Diagnostics Onscreen Viewer
GEMweb Live
Flocked Fiber Swabs
Puritan® patented HydraFlock®
New
Plastic Screen Panels
Plastic Screen Panels
New
Blood and Infusion Warmer
SW300

Print article

Channels

Critical Care

view channel
Image: AI could tackle the huge problem of antimicrobial resistance in intensive care (Photo courtesy of 123RF)

AI Provides Same-Day Prediction of Bloodstream Infection and Antimicrobial Resistance in ICU Patients

Antimicrobial resistance, which refers to the ability of microorganisms to develop defenses against treatments, presents a significant challenge to global healthcare. Infections in the bloodstream can... Read more

Surgical Techniques

view channel
Image: Robots could help close surgeons’ skill gaps and improve patient outcomes (Photo courtesy of Intuitive Surgical)

Robots to Play Larger Role in Surgery Due to Recent AI Developments

Surgeons commonly utilize robots for specific minimally invasive procedures, yet humans still dictate nearly all movements of these machines. Recent advancements in artificial intelligence (AI) and robotics... Read more

Patient Care

view channel
Image: The portable biosensor platform uses printed electrochemical sensors for the rapid, selective detection of Staphylococcus aureus (Photo courtesy of AIMPLAS)

Portable Biosensor Platform to Reduce Hospital-Acquired Infections

Approximately 4 million patients in the European Union acquire healthcare-associated infections (HAIs) or nosocomial infections each year, with around 37,000 deaths directly resulting from these infections,... Read more

Health IT

view channel
Image: First ever institution-specific model provides significant performance advantage over current population-derived models (Photo courtesy of Mount Sinai)

Machine Learning Model Improves Mortality Risk Prediction for Cardiac Surgery Patients

Machine learning algorithms have been deployed to create predictive models in various medical fields, with some demonstrating improved outcomes compared to their standard-of-care counterparts.... Read more

Point of Care

view channel
Image: The acoustic pipette uses sound waves to test for biomarkers in blood (Photo courtesy of Patrick Campbell/CU Boulder)

Handheld, Sound-Based Diagnostic System Delivers Bedside Blood Test Results in An Hour

Patients who go to a doctor for a blood test often have to contend with a needle and syringe, followed by a long wait—sometimes hours or even days—for lab results. Scientists have been working hard to... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.